Filtered By:
Specialty: Respiratory Medicine
This page shows you your search results in order of relevance. This is page number 20.
Order by Relevance | Date
Total 1589 results found since Jan 2013.
Does arterial cannulation site for aortic dissection repair impact surgical outcomes?
CONCLUSIONS: This study found no statistically significant different in rates of stroke or other complications based on cannulation site. Femoral arterial cannulation thus remains a safe and efficient choice for arterial cannulation in the repair of acute type A aortic dissection.PMID:37065559 | PMC:PMC10089872 | DOI:10.21037/jtd-22-576
Source: Journal of Thoracic Disease - April 17, 2023 Category: Respiratory Medicine Authors: Anthony Lemaire Dov Levine Joshua Chao Marlena E Sabatino Hirohisa Ikegami Manabu Takebe Mark J Russo Leonard Y Lee Source Type: research
Preserved Ratio Impaired Spirometry and Risks of Macrovascular, Microvascular Complications and Mortality Among Individuals With Type 2 Diabetes
Chest. 2023 Jun 17:S0012-3692(23)00794-8. doi: 10.1016/j.chest.2023.05.031. Online ahead of print.ABSTRACTBACKGROUND: The prospective associations of preserved ratio impaired spirometry (PRISm) with new-onset macrovascular and microvascular complications and mortality among individuals with type 2 diabetes (T2D) and whether PRISm enhances the prediction ability of an established office-based risk score remains to be elucidated.RESEARCH QUESTION: Can PRISm be used as a predictor of poor prognosis in individuals with T2D?STUDY DESIGN AND METHODS: We included 20,047 study participants with T2D and complete data on spirometry ...
Source: Chest - June 25, 2023 Category: Respiratory Medicine Authors: Guochen Li Matthew D Jankowich Luying Wu Yanqiang Lu Liping Shao Xujia Lu Yulong Fan Chen-Wei Pan Ying Wu Chaofu Ke Source Type: research
Alternatives to warfarin for the treatment of pulmonary emboli: the EINSTEIN-PE Study
The last few years have seen new oral anticoagulant treatments emerge with a major advantage over conventional vitamin K antagonism with warfarin: they have a predictable dose response that negates the need for laboratory monitoring. Dabigatran (Pradaxa), a direct thrombin inhibitor, and rivaroxaban are two such medications licenced for the prevention of stroke in atrial fibrillation. Rivaroxaban (Xiralto) is a direct inhibitor of Factor Xa. The 2011 ROCKET-AF study showed its efficacy in stroke prevention.1 The EINSTEIN-PE study was designed to compare efficacy and safety of fixed-dose oral rivaroxaban therapy against sta...
Source: Thorax - May 8, 2013 Category: Respiratory Medicine Authors: Hynes, G. Tags: Miscellaneous Source Type: research
